Sort
25,944 grants matching “neurodegeneration”
The BrainCellQTL consortium: QTL mapping in the human brain at the single cell level
$2,333,781Panagiotis Roussos · Icahn School Of Medicine At Mount Sinai · U24 · FY2024 · AG
The lipid amidase NAAA as a therapeutic target for Alzheimer's disease
$2,328,624Daniele Piomelli · University Of California-Irvine · RF1 · FY2020 · AG
Pathobiology of Neurodegeneration in C9ORF72 repeat expansion
$2,328,355Leonard Petrucelli · Mayo Clinic Jacksonville · P01 · FY2023 · NS
Structural analysis of tau associated with parenchymal and vascular prion protein amyloidosis
$2,326,501Ruben Vidal · Indiana University Indianapolis · RF1 · FY2021 · AG
Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - Resubmission
$2,324,478Jefferson Kinney · Cleveland Clinic Foundation · P20 · FY2021 · GM
MOLECULAR PATHOGENESIS OF AGE-DEPENDENT CNS DEGENERATION
$2,323,439University Of California San Francisco · P01 · FY2003 · AG
Longitudinal Relationships Among Sleep, Cognition and Alzheimer's Disease Biomarkers: Discerning Causal Associations, Mediators and Susceptibility
$2,322,513Susan S Redline · Brigham And Women'S Hospital · R01 · FY2023 · AG
Multidimensional mapping of vulnerable cell types in humanized Alzheimer's disease mouse models
$2,321,170Inma Cobos · Stanford University · R01 · FY2024 · AG
Neuroinflammation and Alzheimer's Disease Imaging Biomarkers in Midlife Obesity
$2,318,405Cyrus A Raji · Washington University · RF1 · FY2021 · AG
Molecular Biophysics of Mitochondrial Membranes: Defining Future Therapeutic Targ
$2,317,500Yuriy Kirichok · University Of California, San Francisco · DP2 · FY2008 · OD
Engineering Ubiquitin Ligases to Investigate Protein Aggregation and Neurodegener
$2,310,000Shu-Bing Qian · Cornell University · DP2 · FY2009 · OD
DYNAMIC NUCLEAR POLARIZATION SOLID STATE NMR SPECTROMETER FOR BIOMOLECULAR STUDIE
$2,309,300Ann E McDermott · New York Structural Biology Center · S10 · FY2010 · RR
Development of a MT-stabilizing agent for the treatment of tauopathies
$2,309,108Conor Caffrey · University Of California, San Diego · U01 · FY2024 · AG
Watching Proteins Fold (or Misfold) in vivo with Mass Spectrometry
$2,308,098Stephen David Fried · Johns Hopkins University · DP2 · FY2020 · GM
Gene regulatory mechanisms connecting metabolism and Alzheimerâs Disease
$2,307,286Chris Gregg · University Of Utah · RF1 · FY2023 · AG
A mechanistic and dyadic approach to identify how interpersonal conscientiousness supports cognitive health and lowers risk of dementia
$2,300,176Angelina R Sutin · Florida State University · RF1 · FY2023 · AG
National Center for Drug Discovery in Neurodegeneration
$2,299,596Gregory D Cuny · Brigham And Women'S Hospital · U24 · FY2009 · NS
Proteopathies of the Aging Central Nervous
$2,299,012J. David Gladstone Institutes · P01 · FY2004 · AG
High-speed imaging of cortical and white matter microvascular flow in AD/ADRD models
$2,296,464Chris B Schaffer · Cornell University · RF1 · FY2022 · NS
Multi-Ethnic Study of Atherosclerosis- Cellular Exosomes in Neurodegeneration and Dementia (MESA-CEND)
$2,295,557Gagan Deep · Wake Forest University Health Sciences · RF1 · FY2021 · AG
Traffic-related air pollution exacerbates AD-relevant phenotypes in a genetically susceptible rat model via neuroinflammatory mechanism(s)
$2,293,425Pamela J Lein · University Of California At Davis · RF1 · FY2021 · AG
Disease Model Development and Phenotyping Project
$2,291,919Gareth R Howell · Indiana University Indianapolis · U54 · FY2017 · AG
Machine Learning and Large-scale Imaging analytics for dimensional representations of brain trajectories in aging and preclinical Alzheimer's Disease: The brain aging chart and the iSTAGING consortium
$2,290,964Christos Davatzikos · University Of Pennsylvania · RF1 · FY2022 · AG
Pathophysiology of Neurodegenerative Diseases
$2,290,555University Of North Dakota · P20 · FY2002 · RR
Amyloidosis associated proteins in Alzheimerâs disease pathogenesis
$2,290,100Stefan Prokop · University Of Florida · RF1 · FY2021 · AG